OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
FLEX FLOW AI
FLEX FLOW AI builds custom AI automation workflows and agents to streamline operations, boost productivity, and scale your business faster.
Discover the latest updates from industry leaders including Nvidia, OpenAI, and Google—all consolidated into one powerful AI-driven news feed.